The latest closing stock price for SAB Biotherapeutics as of January 21, 2025 is 3.67.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-497 today, roughly 0 times their original investment - a -20.49% compound annual growth rate over 3 years.
The all-time high SAB Biotherapeutics stock closing price was 11.24 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 6.30, which is 71.7% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 2.16, which is 41.1% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 3.63.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-497 today, roughly 0 times their original investment - a -20.49% compound annual growth rate over 3 years.
The all-time high SAB Biotherapeutics stock closing price was 11.24 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 6.30, which is 71.7% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 2.16, which is 41.1% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 3.63.